(Q40471471)

20 September 2017

Immunogenicity of West Nile virus infectious DNA and its noninfectious derivatives. (English)

1 reference

20 September 2017

0 references

Alexey Seregin

1

1 reference

20 September 2017

Ryan Nistler

2

1 reference

20 September 2017

Victoria Borisevich

3

1 reference

20 September 2017

Galina Yamshchikov

4

1 reference

20 September 2017

Elena Chaporgina

5

1 reference

20 September 2017

Chun Wai Kwok

6

1 reference

20 September 2017

Vladimir Yamshchikov

7

1 reference

20 September 2017

language of work or name

English

0 references

publication date

28 August 2006

1 reference

20 September 2017

1 reference

20 September 2017

356

1 reference

20 September 2017

1-2

1 reference

20 September 2017

115-125

1 reference

Characterization of the expression and immunogenicity of poliovirus replicons that encode simian immunodeficiency virus SIVmac239 Gag or envelope SU proteins

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

Biological properties of chimeric West Nile viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

West Nile virus core protein; tetramer structure and ribbon formation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

Augmentation of human influenza A virus-specific cytotoxic T lymphocyte memory by influenza vaccine and adjuvanted carriers (ISCOMS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

DNA vaccines: immunology, application, and optimization*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

A Toll-like receptor recognizes bacterial DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

A plasmid-based self-amplifying Sindbis virus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

Public versus personal serotypes of a viral quasispecies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

Flavivirus Capsid Is a Dimeric Alpha-Helical Protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

DNA and RNA-based vaccines: principles, progress and prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

Flavivirus premembrane protein cleavage and spike heterodimer secretion require the function of the viral proteinase NS3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

A 'minimal' approach in design of flavivirus infectious DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelope proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

Poliovirus replicons encoding the B subunit of Helicobacter pylori urease elicit a Th1 associated immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

Immunization of mice with poliovirus replicons expressing the C-fragment of tetanus toxin protects against lethal challenge with tetanus toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

Alphavirus vectors for gene expression and vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

Noncytopathic flavivirus replicon RNA-based system for expression and delivery of heterologous genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

Regulation of the late events in flavivirus protein processing and maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

A new strategy in design of +RNA virus infectious clones enabling their stable propagation in E. coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

An infectious clone of the West Nile flavivirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

An attenuated West Nile prototype virus is highly immunogenic and protects against the deadly NY99 strain: a candidate for live WN vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

The suitability of yellow fever and Japanese encephalitis vaccines for immunization against West Nile virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

Cancer therapy using a self-replicating RNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

Self-replicating Semliki Forest virus RNA as recombinant vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

inferred from DOI database lookup

7 January 2021

based on heuristic

Processing of the intracellular form of the west Nile virus capsid protein by the viral NS2B-NS3 protease: an in vitro study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

inferred from DOI database lookup

7 January 2021

based on heuristic

Upregulation of signalase processing and induction of prM-E secretion by the flavivirus NS2B-NS3 protease: roles of protease components

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.038

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2006.07.038

1 reference

20 September 2017

1 reference